Related Experiment Video
Updated: Jan 5, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression
Mohammad-Nazir Menbari1, Karim Rahimi2, Abbas Ahmadi3
1Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Aim:
Over-expression of histone deacetylase 8 (HDAC8) has been demonstrated in breast cancer. But the underlying molecular mechanism of HDAC8 on the progression of breast cancer remains unknown. MicroRNAs (miRs) are proposed as important molecules in cancer progression by targeting specific oncogenes or tumor-suppressor genes. Our overall objective was to assess the miR-216b-5p role on HDAC8; and its impacts on breast cancer (BC) progression.
Main Methods:
We acquired cancerous and noncancerous tissues from Iran Tumor Bank (I.T.B). The MDA-MB-231, MCF-7 and MCF-10A BC cell lines were also purchased. The tissue and cell line expression levels of miR-216b-5p and HDAC8 were determined by quantitative real-time PCR (qPCR). We next measured protein levels of HDAC8 by Western blotting assay. The cell cycle, cell proliferation, and colony formation assay were determined. Finally, we investigated the role of HDAC8 using a knockout vector; and confirmed the targeting of 3' untranslated region (3'-UTR) of HDAC8 through miR-216b-5p using a luciferase reporter assay.
Key Findings:
Our results demonstrated a significant decrease in miR-216b-5p, and remarkable increase in HDAC8 levels within human breast cancer tissues and cell lines. The lower levels of miR-216b-5p were negatively correlated with lymph node metastasis and advanced tumor size. The overexpression of miR-216b-5p in BC cell lines inhibited cellular proliferation and progression. HDAC8 was directly down-regulated by miR-216b-5p and knockout of HDAC8 showed the similar effects as miR-216b-5p overexpression.
Significance:
Briefly, HDAC8 is an oncogene that accelerate breast cancer proliferation and progression and miR-216b-5p modulates those functions by binding to HDAC8 3'-UTR.
Insights
MicroRNA-216b-5p inhibits breast cancer progression by targeting histone deacetylase 8 (HDAC8). Lower miR-216b-5p levels correlate with advanced cancer, while its overexpression reduces proliferation and metastasis.
Area of Science:
- Molecular oncology
- Epigenetics
- Cancer biology
Background:
- Histone deacetylase 8 (HDAC8) is overexpressed in breast cancer, but its role in progression is unclear.
- MicroRNAs (miRs) are key regulators in cancer, influencing oncogenes and tumor suppressors.
- Understanding miR-216b-5p's interaction with HDAC8 is crucial for breast cancer research.
Purpose of the Study:
- To investigate the role of miR-216b-5p in regulating HDAC8 expression.
- To determine the impact of the miR-216b-5p/HDAC8 axis on breast cancer progression.
- To elucidate the molecular mechanisms underlying HDAC8's function in breast cancer.
Main Methods:
- Quantitative real-time PCR (qPCR) and Western blotting to assess miR-216b-5p and HDAC8 expression.
- Cell proliferation, cell cycle, and colony formation assays to evaluate cancer progression.
- Luciferase reporter assays and HDAC8 knockout vectors to confirm direct targeting and functional impact.
Main Results:
- Breast cancer tissues and cell lines showed decreased miR-216b-5p and increased HDAC8 levels.
- Reduced miR-216b-5p correlated with lymph node metastasis and larger tumor size.
- miR-216b-5p overexpression inhibited proliferation and progression, directly down-regulating HDAC8.
Conclusions:
- HDAC8 acts as an oncogene promoting breast cancer proliferation and progression.
- miR-216b-5p suppresses these oncogenic functions by binding to the HDAC8 3'-UTR.
- The miR-216b-5p/HDAC8 pathway represents a potential therapeutic target for breast cancer.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Inhibition of Cdk Activity

